Crossmark

Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target

Published Online: 2017-03-10

Published Print: 2017-12

Authors

Roberts, Cai M.

Shahin, Sophia A.

Loeza, Joana

Dellinger, Thanh H.

Williams, John C.

Glackin, Carlotta A.
Funding

Funding for this research was provided by:

Beckman Research Institute, City of Hope (N/A)

National Cancer Institute (Excellence Award)
License Information

Text and Data Mining valid from 2017-03-10

Version of Record valid from 2017-03-10
More Information

Article History

Received: 10 March 2016

Accepted: 4 March 2017

First Online: 10 March 2017

Document is current